Cantor Fitzgerald Downgrades Evelo Biosciences Inc (EVLO) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts EVLO Hot Sheet
Price: $0.00 --0%
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 10
Rating Summary:
2 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 10
Join SI Premium – FREE
Cantor Fitzgerald analyst Kristen Kluska downgraded Evelo Biosciences Inc (NASDAQ: EVLO) from Overweight to Neutral with a price target of $1.00 (from $5.00).
For an analyst ratings summary and ratings history on Evelo Biosciences Inc click here. For more ratings news on Evelo Biosciences Inc click here.
Shares of Evelo Biosciences Inc closed at $0.31 yesterday.
You May Also Be Interested In
- Reddit (RDDT) PT Lowered to $125 at DA Davidson, 'Bottom line is we expect RDDT shares to be challenged in the coming quarter'
- Chevron (CVX) PT Raised to $230 at Morgan Stanley
- Macquarie Upgrades Manila Electric Co. (MER:PM) (MAEOY) to Outperform
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
